News

• Research and Development
• Announce

Notice of Exhibit at “TIDES ASIA 2024”

• Sustainability
• Research and Development

Nippon Shokubai’s Newly Developed Material Contributed the Successful Demonstration of Groundbreaking Renewable Seawater Desalination Plant in Hawaii

• Sustainability
• Research and Development

Development of novel marine biodegradable plastics in the NEDO’s project -Marine biodegradable materials with high gas barrier properties for packaging and agricultural applications-

• Research and Development
• Announce

Notice of Exhibit at “TIDES EUROPE 2023“

• Research and Development
• Announce

Notice of Luncheon Pitch at “EU-Japan Biotech &Pharma Partnering Conference 2023“

• Sustainability
• Research and Development

Nippon Shokubai and Mitsubishi Heavy Industries Conclude Agreement on Joint Development of an Ammonia Cracking System　- Project Aimed at Expanding Use of Hydrogen and Ammonia –

• Sustainability
• Research and Development

JERA, Nippon Shokubai and Chiyoda to Start Development of Ammonia Cracking Technology under NEDO’s Subsidized Project

• Research and Development
• Announce

Notice of Exhibit at “THE BATTERY SHOW EUROPE 2023 “

• Management and Business
• Research and Development

Nippon Shokubai Announces Signing of License Agreement with Rena Therapeutics Inc. 　–to Start Heteroduplex Oligonucleotide (HDO) Synthesis Service for Pharmaceutical Companies and Academia Both Within and Outside Japan–

• Sustainability
• Research and Development

NEDO Adopts Nippon Shokubai and Tokuyama Project to Develop Large Alkaline Water Electrolyzers and Separators Suited to High-pressure Electrolysis

• Sustainability
• Research and Development

Nippon Shokubai participates in COI-NEXT led by the University of Tokyo to jointly develop an integrated agro-industrial GX technologies to contribute to increase food production and green chemical manufacturing

• Research and Development

Completion of the Clinical Research on Knee Osteoarthritis using “MicoCell™” 3D Cell Culture Vessel -Safety of Cell Aggregates Confirmed at our Collaborative Research Clinic-

• Research and Development

Participation in the Innovative Next Generation of Oligonucleotide Therapeutics Project conducted by AMED

• Research and Development

Development of a Coating Material with High Antiviral Effect! – The Inactivation of Human Coronavirus through the New Coating Material –